Spruce Biosciences, Inc.
SPRB
$89.20
$6.097.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 1,265.35% | -103.97% | |||
| Gross Profit | -1,265.35% | 103.97% | |||
| SG&A Expenses | 3.07% | -14.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 205.68% | -81.42% | |||
| Operating Income | -205.68% | 81.42% | |||
| Income Before Tax | -297.29% | 85.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -297.29% | 85.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -297.29% | 85.28% | |||
| EBIT | -205.68% | 81.42% | |||
| EBITDA | -206.37% | 81.46% | |||
| EPS Basic | -317.09% | 85.41% | |||
| Normalized Basic EPS | -317.10% | 85.41% | |||
| EPS Diluted | -317.09% | 85.41% | |||
| Normalized Diluted EPS | -317.10% | 85.41% | |||
| Average Basic Shares Outstanding | -4.74% | 0.89% | |||
| Average Diluted Shares Outstanding | -4.74% | 0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||